-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LlxCH3uVNctzDVglElV6JQ5Xp1wvhQlPwiSaOvDhjgN34BstyUdrYdp53f0wMX7U 9rQbd4h3Q+9fBQIjT1fhiQ== 0000950134-08-000222.txt : 20080107 0000950134-08-000222.hdr.sgml : 20080107 20080107152018 ACCESSION NUMBER: 0000950134-08-000222 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080107 DATE AS OF CHANGE: 20080107 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NovaRay Medical, Inc. CENTRAL INDEX KEY: 0001383529 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 161778998 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-83140 FILM NUMBER: 08514929 BUSINESS ADDRESS: STREET 1: 1850 EMBARCADERO ROAD CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 4089665738 MAIL ADDRESS: STREET 1: 1850 EMBARCADERO ROAD CITY: PALO ALTO STATE: CA ZIP: 94303 FORMER COMPANY: FORMER CONFORMED NAME: Vision Acquisition I, Inc DATE OF NAME CHANGE: 20061213 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PRICE JACK CENTRAL INDEX KEY: 0001421482 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: BUSINESS PHONE: 4089665738 MAIL ADDRESS: STREET 1: 1850 EMBARCADERO ROAD CITY: PALO ALTO STATE: CA ZIP: 94303 SC 13G 1 f36935sc13g.htm SCHEDULE 13G sc13g
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. ______)
NOVARAY MEDICAL, INC.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
[NONE]
(CUSIP Number)
December 27, 2007
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o Rule 13d-1(b)
þ Rule 13d-1(c)
o Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


 

                     
CUSIP No.
 
None 
  Page  
  of   

 

           
1   NAMES OF REPORTING PERSONS
JACK PRICE
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  USA
       
  5   SOLE VOTING POWER
     
NUMBER OF   642,000
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   642,000
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  642,000
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.57%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN


 

13G - Page 3 of 4
             
Item 1.
           
 
           
    (a)   Name of Issuer: NOVARAY MEDICAL, INC.
 
           
    (b)   Address of Issuer’s Principal Executive Offices:
 
           
        1850 Embarcadero Road
Palo Alto, CA 94303
 
           
Item 2.
           
 
           
    (a)   Name of Person Filing:
 
           
        See Item 1 of cover page.
 
           
    (b)   Address of Principal Business Office or, if none, Residence:
 
           
        1850 Embarcadero Road
Palo Alto, CA 94303
 
           
    (c)   Citizenship:
 
           
        See Item 4 of cover page.
 
           
    (d)   Title of Class of Securities: Common Stock
 
           
    (e)   CUSIP number: NONE
 
           
Item 3.   If this statement is filed pursuant to Rules 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
 
           
    Not applicable.
 
           
Item 4.   Ownership:
 
           
    (a)   Amount beneficially owned:
 
           
        See item 9 of cover page. 
 
           
    (b)   Percent of class:
 
           
        See item 11 of cover page.
 
           
    (c)   Number of shares as to which such person has:
 
           
 
      (i)   Sole power to vote or to direct the vote:
 
           
 
          See Item 5 of cover page.
 
           
 
      (ii)   Shared power to vote or to direct the vote:
 
           
 
          See Item 6 of cover page.
 
           
 
      (iii)   Sole power to dispose or to direct the disposition of:
 
           
 
          See Item 7 of cover page.
 
           
 
      (iv)   Shared power to dispose or to direct the disposition of:
 
           
 
          See Item 8 of cover page.

 


 

13G - Page 4 of 4
             
Item 5.   Ownership of Five Percent or Less of a Class:
 
           
    Not applicable.
 
           
Item 6.   Ownership of More than Five Percent on Behalf of Another Person:
 
           
    Not applicable
 
           
Item 7.   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
 
           
    Not applicable.
 
           
Item 8.   Identification and Classification of Members of the Group:
 
           
    Not applicable.
 
           
Item 9.   Notice of Dissolution of Group:
 
           
    Not applicable.
 
           
Item 10.  Certification:
 
           
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
1-7-2008
 
Date
/s/ Jack Price
 
Jack Price

 

-----END PRIVACY-ENHANCED MESSAGE-----